| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Division of Nephrology and
Department of Medicine, Duke University and Durham Veterans Affairs Medical Centers, Durham, NC 27705;
Department of Medicine, University of North Carolina, Chapel Hill, NC 27599; and
§
Department of Pathology, University of Miami School of Medicine, Miami, FL 33101
Leukotrienes, the 5-lipoxygenase (5LO) products of arachidonic acid metabolism, have many proinflammatory actions that have been implicated in the pathogenesis of a variety of inflammatory diseases. To investigate the role of LTs in autoimmune disease, we generated an MRL-lpr/lpr mouse line with a targeted disruption of the 5lo gene. MRL-lpr/lpr mice spontaneously develop autoimmune disease that has many features resembling human systemic lupus erythematosus, including sex-related survival differences; female MRL-lpr/lpr mice experience significant early mortality compared with males. Unexpectedly, we found that mortality was accelerated in male 5LO-deficient MRL-lpr/lpr mice compared with male wild-type MRL-lpr/lpr animals. In contrast, the 5lo mutation had no effect on survival in females. Mortality was also accelerated in male MRL-lpr/lpr mice that were treated chronically with a pharmacological inhibitor of LT synthesis. Furthermore, LT-dependent inflammatory responses are enhanced in male MRL-lpr/lpr mice compared with females, and the 5lo mutation has greater impact on these responses in males. Because immune complex-mediated glomerulonephritis is the major cause of death in MRL-lpr/lpr mice and has been related to arachidonic acid metabolites, we also assessed kidney function and histopathology. In male MRL-lpr/lpr mice, renal plasma flow was significantly reduced in the 5lo-/- compared with the 5lo+/+ group, although there were no differences in the severity of renal histopathology, lymphoid hyperplasia, or arthritis between the groups. These findings suggest that the presence of a functional 5lo gene confers a survival advantage on male MRL-lpr/lpr mice and that, when 5LO function is inhibited, either genetically or pharmacologically, this advantage is abolished.
This article has been cited by other articles:
|
|
 |
|
  C. Pergola, G. Dodt, A. Rossi, E. Neunhoeffer, B. Lawrenz, H. Northoff, B. Samuelsson, O. Radmark, L. Sautebin, and O. Werz ERK-mediated regulation of leukotriene biosynthesis by androgens: A molecular basis for gender differences in inflammation and asthma PNAS, December 16, 2008; 105(50): 19881 - 19886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Goulet, R. C. Griffiths, P. Ruiz, R. B. Mannon, P. Flannery, J. L. Platt, B. H. Koller, and T. M. Coffman Deficiency of 5-Lipoxygenase Accelerates Renal Allograft Rejection in Mice J. Immunol., December 1, 2001; 167(11): 6631 - 6636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Haribabu, M. W. Verghese, D. A. Steeber, D. D. Sellars, C. B. Bock, and R. Snyderman Targeted Disruption of the Leukotriene B4 Receptor in Mice Reveals Its Role in Inflammation and Platelet-activating Factor-induced Anaphylaxis J. Exp. Med., August 8, 2000; 192(3): 433 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Goulet, R. S. Byrum, M. L. Key, M. Nguyen, V. A. Wagoner, and B. H. Koller Genetic Factors Determine the Contribution of Leukotrienes to Acute Inflammatory Responses J. Immunol., May 1, 2000; 164(9): 4899 - 4907. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
